Effect of Cabergoline on Weight and Glucose Tolerance
NCT01395602
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Body Weight
Impaired Glucose Tolerance in Obese
Interventions
DRUG:
Cabergoline
OTHER:
placebo
Sponsor
Columbia University